-
-
-
-
-
-
-
Nektar Therapeutics reports positive 52-week data for alopecia areata drug trial
-
-
-
-
-
-
-
Nektar Therapeutics Announces Proposed Public Offering
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) Prices 4.26M Share Offering at $23.50/sh
-
-
-
-
-
-
-
Form S-3 NEKTAR THERAPEUTICS
-
-
-
-
71,086 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

